FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2316315960> ?p ?o ?g. }

• W2316315960 endingPage "363" @default.
• W2316315960 startingPage "357" @default.
• W2316315960 abstract "5-S-Cysteinyldopa (5-S-CD) has been used as a biochemical marker of melanoma progression. Recently we have shown that the serum level of 5-S-CD is a sensitive and specific marker in predicting distant metastases. In melanocytes and melanoma cells, cysteinyldopa isomers are oxidized to phaeomelanin, the yellow to reddish melanin pigment. In this study we have developed a new method to measure levels of phaeomelanin in serum samples and have evaluated its clinical significance. The method is based on the production of 4-amino-3-hydroxyphenylalanine (4-AHP) and 3-amino-4-hydroxyphenylalanine (3-AHP) on reductive hydrolysis of phaeomelanin with hydriodic acid. 3-AHP is also derived from 3-nitrotyrosine-containing proteins. The isomeric 4-AHP and 3-AHP can be separated by high performance liquid chromatography. The mean +/- SD serum levels of 5-S-CD in control subjects (n = 36), in melanoma patients without recurrence (n = 92) and in melanoma patients with metastases (n = 24) were 2.7 +/- 1.2 nM (median 2.3 nM), 4.0 +/- 1.6 nM (median 3.8 nM) and 72 +/- 105 nM (median 35 nM), respectively. The serum levels of 4-AHP in these three groups were 45 +/- 21 nM (median 31 nM), 80 +/- 75 nM (median 53 nM) and 306 +/- 627 nM (median 133 nM), respectively. The serum levels of 4-AHP in patients with metastases (100 samples from 15 patients with progressive disease) correlated well (r = 0.887) with serum levels of 5-S-CD, while serum levels of 3-AHP did not (r = 0.240). The serum 5-S-CD and 4-AHP levels were serially analysed in the 15 patients with progressive disease. In two patients (13%), serum 4-AHP levels were elevated to abnormal levels before the serum 5-S-CD levels exceeded the cut-off value of 10 nM. In five patients (33%), the serum 4-AHP levels rose concurrently with the serum 5-S-CD levels. In the remaining eight patients (54%), serum 4-AHP levels were of less diagnostic value. Thus, the serum phaeomelanin level appears to be less sensitive than the serum 5-S-CD level in detecting distant metastases." @default.
• W2316315960 created "2016-06-24" @default.
• W2316315960 creator A5010983774 @default.
• W2316315960 creator A5022391806 @default.
• W2316315960 creator A5052499314 @default.
• W2316315960 creator A5053073772 @default.
• W2316315960 creator A5064652216 @default.
• W2316315960 date "2003-08-01" @default.
• W2316315960 modified "2023-10-12" @default.
• W2316315960 title "Comparison of phaeomelanin and its precursor 5-S-cysteinyldopa in the serum of melanoma patients" @default.
• W2316315960 cites W1850368124 @default.
• W2316315960 cites W1902676283 @default.
• W2316315960 cites W1974188559 @default.
• W2316315960 cites W1983077538 @default.
• W2316315960 cites W1984979015 @default.
• W2316315960 cites W2020567919 @default.
• W2316315960 cites W2037094500 @default.
• W2316315960 cites W2039852371 @default.
• W2316315960 cites W2045818173 @default.
• W2316315960 cites W2046684403 @default.
• W2316315960 cites W2054288725 @default.
• W2316315960 cites W2065245887 @default.
• W2316315960 cites W2080469152 @default.
• W2316315960 cites W2090977353 @default.
• W2316315960 cites W2091161222 @default.
• W2316315960 cites W2128234215 @default.
• W2316315960 cites W2320316126 @default.
• W2316315960 cites W2325148458 @default.
• W2316315960 doi "https://doi.org/10.1097/00008390-200308000-00004" @default.
• W2316315960 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12883361" @default.
• W2316315960 hasPublicationYear "2003" @default.
• W2316315960 type Work @default.
• W2316315960 sameAs 2316315960 @default.
• W2316315960 citedByCount "16" @default.
• W2316315960 countsByYear W23163159602016 @default.
• W2316315960 countsByYear W23163159602020 @default.
• W2316315960 countsByYear W23163159602021 @default.
• W2316315960 countsByYear W23163159602023 @default.
• W2316315960 crossrefType "journal-article" @default.
• W2316315960 hasAuthorship W2316315960A5010983774 @default.
• W2316315960 hasAuthorship W2316315960A5022391806 @default.
• W2316315960 hasAuthorship W2316315960A5052499314 @default.
• W2316315960 hasAuthorship W2316315960A5053073772 @default.
• W2316315960 hasAuthorship W2316315960A5064652216 @default.
• W2316315960 hasConcept C107538193 @default.
• W2316315960 hasConcept C185592680 @default.
• W2316315960 hasConcept C2777658100 @default.
• W2316315960 hasConcept C502942594 @default.
• W2316315960 hasConcept C55493867 @default.
• W2316315960 hasConcept C71924100 @default.
• W2316315960 hasConcept C90924648 @default.
• W2316315960 hasConceptScore W2316315960C107538193 @default.
• W2316315960 hasConceptScore W2316315960C185592680 @default.
• W2316315960 hasConceptScore W2316315960C2777658100 @default.
• W2316315960 hasConceptScore W2316315960C502942594 @default.
• W2316315960 hasConceptScore W2316315960C55493867 @default.
• W2316315960 hasConceptScore W2316315960C71924100 @default.
• W2316315960 hasConceptScore W2316315960C90924648 @default.
• W2316315960 hasIssue "4" @default.
• W2316315960 hasLocation W23163159601 @default.
• W2316315960 hasLocation W23163159602 @default.
• W2316315960 hasOpenAccess W2316315960 @default.
• W2316315960 hasPrimaryLocation W23163159601 @default.
• W2316315960 hasRelatedWork W1531601525 @default.
• W2316315960 hasRelatedWork W2606230654 @default.
• W2316315960 hasRelatedWork W2607424097 @default.
• W2316315960 hasRelatedWork W2748952813 @default.
• W2316315960 hasRelatedWork W2899084033 @default.
• W2316315960 hasRelatedWork W2948807893 @default.
• W2316315960 hasRelatedWork W2953403851 @default.
• W2316315960 hasRelatedWork W3031052312 @default.
• W2316315960 hasRelatedWork W4362634222 @default.
• W2316315960 hasRelatedWork W2778153218 @default.
• W2316315960 hasVolume "13" @default.
• W2316315960 isParatext "false" @default.
• W2316315960 isRetracted "false" @default.
• W2316315960 magId "2316315960" @default.
• W2316315960 workType "article" @default.